IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 1 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,208 | +20.8% | 3,450 | +6.2% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 3,250 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 3,250 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 3,250 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 3,250 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | -25.0% | 3,250 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | 0.0% | 3,250 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | -82.6% | 3,250 | -48.0% | 0.00% | – |
| Q4 2020 | $23,000 | +228.6% | 6,250 | +92.3% | 0.00% | – |
| Q3 2020 | $7,000 | +250.0% | 3,250 | +160.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | -50.0% | 1,250 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | +33.3% | 1,250 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -72.7% | 1,250 | 0.0% | 0.00% | – |
| Q3 2018 | $11,000 | – | 1,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |